Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS(G12D) Inhibitor, in Colorectal Cancer Treatment. Kataoka M, Kitazawa M, Nakamura S, Koyama M, et al. Anticancer Res 2023;43:4341-4348.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kataoka M, Kitazawa M, Nakamura S, Koyama M, et al. Cetuximab Enhances the Efficacy of MRTX1133, a Novel KRAS(G12D) Inhibitor, in Colorectal Cancer Treatment. Anticancer Res 2023;43:4341-4348.
PMID: 37772552